Search Results : Cancer

1954 interactions found:

Novel Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
WT1 transcription factor
Name2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3
Pathway 1
  • Transcriptional regulation of testis differentiation
  • Negative Regulation of CDH1 Gene Transcription
  • Nephron development
Pathway 2
  • Keratan sulfate biosynthesis
  • O-linked glycosylation of mucins
  • PD-L1(CD274) glycosylation and translocation to plasma membrane
Drugs 1
Drugs 2
Diseases 1
  • Nephrotic syndrome and focal segmental glomerulosclerosis
  • 46,XY disorders of sex development (Disorders of gonadal development), including: Gonadal agenesis; Complete and partial gonadal dysgenesis; Testis regression; Ovotesticular DSD
Diseases 2
Novel
Novel
Name 1
double C2 domain alpha
Name2
heparan sulfate-glucosamine 3-sulfotransferase 4
Pathway 1
Pathway 2
  • HS-GAG biosynthesis
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
nuclear factor related to kappaB binding protein
Name2
opioid binding protein/cell adhesion molecule like
Pathway 1
  • UCH proteinases
  • DNA Damage Recognition in GG-NER
Pathway 2
  • Post-translational modification: synthesis of GPI-anchored proteins
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
alkylglycerone phosphate synthase
Name2
potassium voltage-gated channel subfamily H member 7
Pathway 1
  • Plasmalogen biosynthesis
  • Peroxisomal protein import
  • Peroxisomal protein import
  • TYSND1 cleaves peroxisomal proteins
Pathway 2
  • Voltage gated Potassium channels
Drugs 1
Drugs 2
  • Enflurane
  • Ibutilide
  • Amitriptyline
  • Doxazosin
  • Promethazine
  • Miconazole
  • Amiodarone
  • Terazosin
  • Vanoxerine
  • Silodosin
Diseases 1
  • Rhizomelic chondrodysplasia punctata, including: Rhizomelic chondrodysplasia punctata, type I (RCDP1); Rhizomelic chondrodysplasia punctata, type II (RCDP2); Rhizomelic chondrodysplasia punctata, type III (RCDP3)
Diseases 2
Novel
Novel
Symbols
Name 1
T-box transcription factor 1
Name2
MORC family CW-type zinc finger 3
Pathway 1
  • Cardiogenesis
Pathway 2
Drugs 1
Drugs 2
Diseases 1
  • Velocardiofacial syndrome
  • Conotruncal heart malformations, including: Double-outlet right ventricle; Persistent truncus arteriosus; Conotruncal anomaly face syndrome
  • Other well-defined immunodeficiency syndromes, including the following seven diseases: Wiskott-Aldrich syndrome; DiGeorge syndrome; Hyper-IgE syndrome; X-linked lymphoproliferative syndrome; Immunodeficiency, Polyendocrinopathy, Enteropathy, X-linked Syndrome (IPEX); Cartilage-Hair Hypoplasia; Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
Diseases 2
Novel
Novel
Name 1
tubulin beta 4A class IVa
Name2
strawberry notch homolog 2
Pathway 1
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
  • Gap junction assembly
  • MHC class II antigen presentation
  • Separation of Sister Chromatids
  • Resolution of Sister Chromatid Cohesion
  • Regulation of PLK1 Activity at G2/M Transition
  • HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Prefoldin mediated transfer of substrate to CCT/TriC
  • Formation of tubulin folding intermediates by CCT/TriC
  • Post-chaperonin tubulin folding pathway
  • Recycling pathway of L1
  • Recycling pathway of L1
  • Hedgehog 'off' state
  • Anchoring of the basal body to the plasma membrane
  • Cargo trafficking to the periciliary membrane
  • Intraflagellar transport
  • RHO GTPases activate IQGAPs
  • RHO GTPases Activate Formins
  • COPI-mediated anterograde transport
  • COPI-dependent Golgi-to-ER retrograde traffic
  • COPI-independent Golgi-to-ER retrograde traffic
  • Mitotic Prometaphase
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • AURKA Activation by TPX2
  • Carboxyterminal post-translational modifications of tubulin
  • Carboxyterminal post-translational modifications of tubulin
  • HCMV Early Events
  • Assembly and cell surface presentation of NMDA receptors
  • Activation of AMPK downstream of NMDARs
  • Aggrephagy
  • Aggrephagy
  • EML4 and NUDC in mitotic spindle formation
  • Sealing of the nuclear envelope (NE) by ESCRT-III
  • Kinesins
  • PKR-mediated signaling
Pathway 2
Drugs 1
  • Epothilone D
  • Patupilone
  • CYT997
  • ZEN-012
  • Artenimol
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
proline rich 5
Name2
signal peptide, CUB domain and EGF like domain containing 1
Pathway 1
  • PIP3 activates AKT signaling
  • CD28 dependent PI3K/Akt signaling
  • VEGFR2 mediated vascular permeability
  • Constitutive Signaling by AKT1 E17K in Cancer
  • Regulation of TP53 Degradation
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
Pathway 2
  • Degradation of the extracellular matrix
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
ATPase H+ transporting V1 subunit A
Name2
limbic system associated membrane protein
Pathway 1
  • ROS and RNS production in phagocytes
  • Insulin receptor recycling
  • Transferrin endocytosis and recycling
  • Amino acids regulate mTORC1
  • Ion channel transport
  • Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy
Pathway 2
  • Post-translational modification: synthesis of GPI-anchored proteins
Drugs 1
  • Alendronic acid
  • Etidronic acid
  • Tiludronic acid
  • Bafilomycin A1
  • Bafilomycin B1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
collagen type XV alpha 1 chain
Name2
growth arrest specific 1
Pathway 1
  • Collagen degradation
  • Collagen biosynthesis and modifying enzymes
  • Assembly of collagen fibrils and other multimeric structures
  • Collagen chain trimerization
Pathway 2
  • Ligand-receptor interactions
  • Activation of SMO
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
translation machinery associated 16 homolog
Name2
follistatin like 5
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
FKBP prolyl isomerase family member 15
Name2
deleted in esophageal cancer 1
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
coiled-coil domain containing 91
Name2
transmembrane O-mannosyltransferase targeting cadherins 1
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
3-hydroxyisobutyryl-CoA hydrolase
Name2
major facilitator superfamily domain containing 6
Pathway 1
  • Branched-chain amino acid catabolism
  • 3-hydroxyisobutyryl-CoA hydrolase deficiency
Pathway 2
Drugs 1
  • Quercetin
Drugs 2
Diseases 1
  • Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
Diseases 2
Novel
Novel
Symbols
Name 1
N-acetyltransferase 1
Name2
CUB and Sushi multiple domains 1
Pathway 1
  • Acetylation
  • Paracetamol ADME
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
ATPase H+ transporting V0 subunit b
Name2
bactericidal permeability increasing protein
Pathway 1
  • ROS and RNS production in phagocytes
  • Insulin receptor recycling
  • Transferrin endocytosis and recycling
  • Amino acids regulate mTORC1
  • Ion channel transport
  • Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy
Pathway 2
  • Toll Like Receptor 4 (TLR4) Cascade
  • Neutrophil degranulation
  • Antimicrobial peptides
Drugs 1
  • Tiludronic acid
Drugs 2
  • Di-Stearoyl-3-Sn-Phosphatidylcholine
Diseases 1
Diseases 2
Novel
Novel
Name 1
adenosine deaminase RNA specific B2 (inactive)
Name2
La ribonucleoprotein 4B
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
CREB regulated transcription coactivator 3
Name2
hyaluronan and proteoglycan link protein 3
Pathway 1
  • Transcriptional activation of mitochondrial biogenesis
  • Heme signaling
  • Expression of BMAL (ARNTL), CLOCK, and NPAS2
Pathway 2
Drugs 1
Drugs 2
  • Hyaluronic acid
Diseases 1
Diseases 2
Novel
Novel
Name 1
RAB2B, member RAS oncogene family
Name2
solute carrier family 25 member 21
Pathway 1
  • RAB geranylgeranylation
Pathway 2
  • Lysine catabolism
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
heterogeneous nuclear ribonucleoprotein L like
Name2
zinc finger protein 311
Pathway 1
Pathway 2
  • Generic Transcription Pathway
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
zDHHC palmitoyltransferase 8
Name2
microtubule associated monooxygenase, calponin and LIM domain containing 3
Pathway 1
  • HDL assembly
  • Maturation of spike protein
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
WT1 transcription factor
Name2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3
Pathway 1
  • Transcriptional regulation of testis differentiation
  • Negative Regulation of CDH1 Gene Transcription
  • Nephron development
Pathway 2
  • Keratan sulfate biosynthesis
  • O-linked glycosylation of mucins
  • PD-L1(CD274) glycosylation and translocation to plasma membrane
Drugs 1
Drugs 2
Diseases 1
  • Nephrotic syndrome and focal segmental glomerulosclerosis
  • 46,XY disorders of sex development (Disorders of gonadal development), including: Gonadal agenesis; Complete and partial gonadal dysgenesis; Testis regression; Ovotesticular DSD
Diseases 2
Novel
Name 1
double C2 domain alpha
Name2
heparan sulfate-glucosamine 3-sulfotransferase 4
Pathway 1
Pathway 2
  • HS-GAG biosynthesis
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
nuclear factor related to kappaB binding protein
Name2
opioid binding protein/cell adhesion molecule like
Pathway 1
  • UCH proteinases
  • DNA Damage Recognition in GG-NER
Pathway 2
  • Post-translational modification: synthesis of GPI-anchored proteins
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
alkylglycerone phosphate synthase
Name2
potassium voltage-gated channel subfamily H member 7
Pathway 1
  • Plasmalogen biosynthesis
  • Peroxisomal protein import
  • Peroxisomal protein import
  • TYSND1 cleaves peroxisomal proteins
Pathway 2
  • Voltage gated Potassium channels
Drugs 1
Drugs 2
  • Enflurane
  • Ibutilide
  • Amitriptyline
  • Doxazosin
  • Promethazine
  • Miconazole
  • Amiodarone
  • Terazosin
  • Vanoxerine
  • Silodosin
Diseases 1
  • Rhizomelic chondrodysplasia punctata, including: Rhizomelic chondrodysplasia punctata, type I (RCDP1); Rhizomelic chondrodysplasia punctata, type II (RCDP2); Rhizomelic chondrodysplasia punctata, type III (RCDP3)
Diseases 2
Novel
Symbols
Name 1
T-box transcription factor 1
Name2
MORC family CW-type zinc finger 3
Pathway 1
  • Cardiogenesis
Pathway 2
Drugs 1
Drugs 2
Diseases 1
  • Velocardiofacial syndrome
  • Conotruncal heart malformations, including: Double-outlet right ventricle; Persistent truncus arteriosus; Conotruncal anomaly face syndrome
  • Other well-defined immunodeficiency syndromes, including the following seven diseases: Wiskott-Aldrich syndrome; DiGeorge syndrome; Hyper-IgE syndrome; X-linked lymphoproliferative syndrome; Immunodeficiency, Polyendocrinopathy, Enteropathy, X-linked Syndrome (IPEX); Cartilage-Hair Hypoplasia; Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
Diseases 2
Novel
Name 1
tubulin beta 4A class IVa
Name2
strawberry notch homolog 2
Pathway 1
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
  • Gap junction assembly
  • MHC class II antigen presentation
  • Separation of Sister Chromatids
  • Resolution of Sister Chromatid Cohesion
  • Regulation of PLK1 Activity at G2/M Transition
  • HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Prefoldin mediated transfer of substrate to CCT/TriC
  • Formation of tubulin folding intermediates by CCT/TriC
  • Post-chaperonin tubulin folding pathway
  • Recycling pathway of L1
  • Recycling pathway of L1
  • Hedgehog 'off' state
  • Anchoring of the basal body to the plasma membrane
  • Cargo trafficking to the periciliary membrane
  • Intraflagellar transport
  • RHO GTPases activate IQGAPs
  • RHO GTPases Activate Formins
  • COPI-mediated anterograde transport
  • COPI-dependent Golgi-to-ER retrograde traffic
  • COPI-independent Golgi-to-ER retrograde traffic
  • Mitotic Prometaphase
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • AURKA Activation by TPX2
  • Carboxyterminal post-translational modifications of tubulin
  • Carboxyterminal post-translational modifications of tubulin
  • HCMV Early Events
  • Assembly and cell surface presentation of NMDA receptors
  • Activation of AMPK downstream of NMDARs
  • Aggrephagy
  • Aggrephagy
  • EML4 and NUDC in mitotic spindle formation
  • Sealing of the nuclear envelope (NE) by ESCRT-III
  • Kinesins
  • PKR-mediated signaling
Pathway 2
Drugs 1
  • Epothilone D
  • Patupilone
  • CYT997
  • ZEN-012
  • Artenimol
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
proline rich 5
Name2
signal peptide, CUB domain and EGF like domain containing 1
Pathway 1
  • PIP3 activates AKT signaling
  • CD28 dependent PI3K/Akt signaling
  • VEGFR2 mediated vascular permeability
  • Constitutive Signaling by AKT1 E17K in Cancer
  • Regulation of TP53 Degradation
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
Pathway 2
  • Degradation of the extracellular matrix
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
ATPase H+ transporting V1 subunit A
Name2
limbic system associated membrane protein
Pathway 1
  • ROS and RNS production in phagocytes
  • Insulin receptor recycling
  • Transferrin endocytosis and recycling
  • Amino acids regulate mTORC1
  • Ion channel transport
  • Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy
Pathway 2
  • Post-translational modification: synthesis of GPI-anchored proteins
Drugs 1
  • Alendronic acid
  • Etidronic acid
  • Tiludronic acid
  • Bafilomycin A1
  • Bafilomycin B1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
collagen type XV alpha 1 chain
Name2
growth arrest specific 1
Pathway 1
  • Collagen degradation
  • Collagen biosynthesis and modifying enzymes
  • Assembly of collagen fibrils and other multimeric structures
  • Collagen chain trimerization
Pathway 2
  • Ligand-receptor interactions
  • Activation of SMO
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
translation machinery associated 16 homolog
Name2
follistatin like 5
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
FKBP prolyl isomerase family member 15
Name2
deleted in esophageal cancer 1
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
coiled-coil domain containing 91
Name2
transmembrane O-mannosyltransferase targeting cadherins 1
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
3-hydroxyisobutyryl-CoA hydrolase
Name2
major facilitator superfamily domain containing 6
Pathway 1
  • Branched-chain amino acid catabolism
  • 3-hydroxyisobutyryl-CoA hydrolase deficiency
Pathway 2
Drugs 1
  • Quercetin
Drugs 2
Diseases 1
  • Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
Diseases 2
Novel
Symbols
Name 1
N-acetyltransferase 1
Name2
CUB and Sushi multiple domains 1
Pathway 1
  • Acetylation
  • Paracetamol ADME
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
ATPase H+ transporting V0 subunit b
Name2
bactericidal permeability increasing protein
Pathway 1
  • ROS and RNS production in phagocytes
  • Insulin receptor recycling
  • Transferrin endocytosis and recycling
  • Amino acids regulate mTORC1
  • Ion channel transport
  • Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy
Pathway 2
  • Toll Like Receptor 4 (TLR4) Cascade
  • Neutrophil degranulation
  • Antimicrobial peptides
Drugs 1
  • Tiludronic acid
Drugs 2
  • Di-Stearoyl-3-Sn-Phosphatidylcholine
Diseases 1
Diseases 2
Novel
Name 1
adenosine deaminase RNA specific B2 (inactive)
Name2
La ribonucleoprotein 4B
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
CREB regulated transcription coactivator 3
Name2
hyaluronan and proteoglycan link protein 3
Pathway 1
  • Transcriptional activation of mitochondrial biogenesis
  • Heme signaling
  • Expression of BMAL (ARNTL), CLOCK, and NPAS2
Pathway 2
Drugs 1
Drugs 2
  • Hyaluronic acid
Diseases 1
Diseases 2
Novel
Name 1
RAB2B, member RAS oncogene family
Name2
solute carrier family 25 member 21
Pathway 1
  • RAB geranylgeranylation
Pathway 2
  • Lysine catabolism
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
heterogeneous nuclear ribonucleoprotein L like
Name2
zinc finger protein 311
Pathway 1
Pathway 2
  • Generic Transcription Pathway
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
zDHHC palmitoyltransferase 8
Name2
microtubule associated monooxygenase, calponin and LIM domain containing 3
Pathway 1
  • HDL assembly
  • Maturation of spike protein
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2

Page 4 out of 98 pages

© Madhavi K. Ganapathiraju 2012-2025